Literature DB >> 25956153

Parametric time-to-onset models were developed to improve causality assessment of adverse drug reactions from antidiabetic drugs.

Joep H G Scholl1, Peter M van de Ven2, Eugène P van Puijenbroek3.   

Abstract

OBJECTIVES: The aim of this study was to investigate whether the time to onset (TTO) of common adverse drug reactions (ADRs) of antidiabetic drugs could be modeled using parametric distributions and whether these TTO distributions were dependent on patient characteristics. Furthermore, information relevant for daily clinical practice was to be obtained. STUDY DESIGN AND
SETTING: We performed an exploratory TTO modeling study, using a cohort of diabetes mellitus patients. Four parametric distributions (exponential, lognormal, gamma, and Weibull) were compared in terms of their goodness of fit. Covariates that could influence the TTO were investigated. In addition, TTO mean and median values were summarized for use in clinical practice.
RESULTS: Overall, the gamma distribution provided the best goodness of fit, although differences with the Weibull distribution were negligible in some instances. No differences in TTO distributions between different antidiabetic drugs for a given ADR were found. The TTO was influenced by suspected concomitant medication for metformin-associated diarrhea. Mean and median TTO values were similar for different drug-ADR combinations.
CONCLUSION: Our study shows that the TTO of common ADRs associated with antidiabetic drugs can be modeled using the gamma or Weibull distribution. Furthermore, clinically relevant information about these ADRs can be obtained.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADR; Causality assessment; Latency; Parametric modeling; Pharmacovigilance; Time to onset

Mesh:

Substances:

Year:  2015        PMID: 25956153     DOI: 10.1016/j.jclinepi.2015.03.001

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  1 in total

1.  Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.

Authors:  Petra Denig; Eugène P van Puijenbroek; Nashwa Soliman; Peter G M Mol; Sieta T de Vries
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-06-17       Impact factor: 2.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.